Drug Approval | September 10, 2025
FDA prohibits Sun Pharma's Halol Plant from exporting drugs to US
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Vonvendi is the only recombinant Von Willebrand factor replacement therapy with approved indications in adults and children with VWD
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
Guidelines aim to establish state-regulated veterinary blood banks
The ‘265 Patent is based on Enanta’s July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists
The accelerated approval is supported by results from part 1 of the ESSENCE trial
The randomized, double-blind, placebo-controlled Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102 in healthy participants
Subscribe To Our Newsletter & Stay Updated
